It was alleged that Mumbai-based Metropolis Health Care abused its dominant position and used the informant (Sudheesh Goel) as a platform to enter the regional market of Chandigarh, and was misusing the latter's brand value and market reputation.
Sudheesh Goel was running a pathology lab in Chandigarh in the name of Dr Goel's S K Diagnostic Centre. In 2011, both sides entered into an agreement whereby Metropolis would take over the informant's existing business in Chandigarh.
"As such, the facts of the case do not highlight any competition issue which requires intervention," it noted.
According to CCI, the allegation regarding the inability of the informant and other regional players to compete with the opposite party because of their expanding business in Chandigarh seems to be misplaced.
"The Commission is of the view that the issue itself is anti-thesis to the spirit of competition as enshrined under the (Competition) Act. The Preamble and other provisions of the Act suggest that objective of the Act is to protect the process of competition, not the individual competitors," the order, dated November 17, said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
